Linda R Mileshkin (Linda Mileshkin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Endometrial Cancer

Prognostic Factors

Top Venues

Nature medicine

Journal of gynecologic oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Rebecca S Kristeleit, Alexandra Leary, Ana Oaknin, Andres Redondo, Angela George, Stephen Chui, Aicha Seiller, Mario Liste-Hermoso, Jenna Willis, Colby S Shemesh, Jim Xiao, Kevin K Lin, Luciana Molinero, Yinghui Guan, Isabelle L Ray-Coquard, Linda R Mileshkin
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers. British journal of cancer 131 (5) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Rebecca S Kristeleit, Alexandra Leary, Ana Oaknin, Andres Redondo, Angela George, Stephen Chui, Aicha Seiller, Mario Liste-Hermoso, Jenna Willis, Colby S Shemesh, Jim Xiao, Kevin K Lin, Luciana Molinero, Yinghui Guan, Isabelle L Ray-Coquard, Linda R Mileshkin
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers. British journal of cancer (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine (2024)
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen, Ludy C H W Lutgens, Melanie E Powell, Linda R Mileshkin, Helen Mackay, Alexandra Leary, Dionyssios Katsaros, Hans W Nijman, Stephanie M de Boer, Remi A Nout, Marco de Bruyn, David Church, Vincent T H B M Smit, Carien L Creutzberg, Viktor Hendrik Koelzer, Tjalling Bosse
Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nature medicine 30 (7) (2024)
George Au-Yeung, Linda R Mileshkin, David D L Bowtell
CCNE1 Amplification as a Therapeutic Target. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
George Au-Yeung, Linda R Mileshkin, David D L Bowtell
CCNE1 Amplification as a Therapeutic Target. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Nikki L Burdett, Madelynne O Willis, Kathryn Alsop, Allison L Hunt, Ahwan Pandey, Phineas T Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sian Fereday, Joy Hendley, Dale W Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L Hood, Katlin N Wilson, Kelly A Conrads, Kathleen I Pishas, Sumitra Ananda, Clare L Scott, Yoland Antill, Orla McNally, Linda R Mileshkin, Anne Hamilton, George Au-Yeung, Lisa Devereux, Heather Thorne, Andrea H Bild, Nicholas W Bateman, G Larry Maxwell, Jeffrey T Chang, Thomas P Conrads, Brad H Nelson, David D L Bowtell, Elizabeth L Christie
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature genetics 55 (3) (2023)
George Au-Yeung, Linda R Mileshkin, David D L Bowtell
CCNE1 Amplification as a Therapeutic Target. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nikki L Burdett, Madelynne O Willis, Kathryn Alsop, Allison L Hunt, Ahwan Pandey, Phineas T Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sian Fereday, Joy Hendley, Dale W Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L Hood, Katlin N Wilson, Kelly A Conrads, Kathleen I Pishas, Sumitra Ananda, Clare L Scott, Yoland Antill, Orla McNally, Linda R Mileshkin, Anne Hamilton, George Au-Yeung, Lisa Devereux, Heather Thorne, Andrea H Bild, Nicholas W Bateman, G Larry Maxwell, Jeffrey T Chang, Thomas P Conrads, Brad H Nelson, David D L Bowtell, Elizabeth L Christie
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature genetics 55 (3) (2023)
Nikki L Burdett, Madelynne O Willis, Kathryn Alsop, Allison L Hunt, Ahwan Pandey, Phineas T Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sian Fereday, Joy Hendley, Dale W Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L Hood, Katlin N Wilson, Kelly A Conrads, Kathleen I Pishas, Sumitra Ananda, Clare L Scott, Yoland Antill, Orla McNally, Linda R Mileshkin, Anne Hamilton, George Au-Yeung, Lisa Devereux, Heather Thorne, Andrea H Bild, Nicholas W Bateman, G Larry Maxwell, Jeffrey T Chang, Thomas P Conrads, Brad H Nelson, David D L Bowtell, Elizabeth L Christie
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature genetics (2023)
Lisa Guccione, Krista Fisher, Linda R Mileshkin, Richard William Tothill, David D L Bowtell, Stephen Quinn, Anna De Fazio, Christos S Karapetis, Nicholas Wilcken, Madhu Singh, Christopher B Steer, Bo Gao, Mark Warren, Ian M Collins, Narayan Karanth, Cindy Bryant, Penelope Schofield
Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (10) (2022)
Jeffery S Ross, Ethan S Sokol, Holger Moch, Linda R Mileshkin, Giulia Baciarello, Ferran Losa, Andreas Beringer, Marlene Thomas, Julia A Elvin, Nhu Ngo, Dexter X Jin, Alwin Krämer
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design. The oncologist 26 (3) (2020)